PHARMING GRP SP. ADRS (PHG) — Long-term Investment Intensity
PHARMING GRP SP. ADRS (PHG) has a Long-term Investment Intensity of 1.7% as of December 2025. Long-term investments of €8.65 Million represent 1.7% of total assets of €499.96 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check PHARMING GRP SP. ADRS investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
PHARMING GRP SP. ADRS Long-term Investment Intensity (2021–2025)
This chart shows how PHARMING GRP SP. ADRS's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 1.7%, reflecting long-term investments of €8.65 Million against total assets of €499.96 Million EUR. Explore how well can PHARMING GRP SP. ADRS service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for PHARMING GRP SP. ADRS (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is PHARMING GRP SP. ADRS worth.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.7% | €8.65 Million | €499.96 Million | ▲ +0.7 pp |
| 2024 | 1.1% | €4.23 Million | €399.99 Million | ▼ -1.2 pp |
| 2023 | 2.2% | €10.40 Million | €462.85 Million | ▼ 0.0 pp |
| 2022 | 2.3% | €9.73 Million | €425.80 Million | ▲ +0.1 pp |
| 2021 | 2.2% | €8.65 Million | €397.31 Million | — |